CSA BioTech is an emerging biopharmaceutical company focused on commercializing a novel class of patented compounds known as ceragenins or CSAs. These compounds have broad-spectrum activity mimicking those of endogenous antimicrobial peptides such as LL-37. CSAs, however, are not peptides; rather synthetic small molecules that can be manufactured at large scale and are not subject to proteolytic degradation.
CSAs are anti-inflammatory, immune-stimulant antimicrobials (including Multi Drug Resistant strains and carbapenem resistant strains). The technology is the subject of two multimillion-dollar NIH funded research grants.
Our focus areas are in animal health, food safety products, pharmaceuticals, and consumer products. There are hundreds of uses and applications of CSAs.